Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

P.M.W. Bath; A. Adami; D. Bereczki; E. Berge; M.Z. Beridze; Lesley Cala; A. Casado; V. Caso; H. Chang; H.K. Christensen; R.D. Collins; A. Członkowska; R.A. Dineen; A.E. Etribi; A. Ghani; J.H. Gommans; P. Koumellis; A.C. Laska; K.R. Lees; J.C. Navarro; G.C. Ntaios; S. Öztürk; S.J. Phillips; S.J. Pocock; K.T. Prasad; P. Scutt; H.A.R. De Silva; S.Z. Szatmári; S. Utton; Y. Wang; M.W. Joanna; D.K. Whynes; L. Wong; L.J. Woodhouse; N. Sprigg

doi:10.1111/ijs.12308

Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

P.M.W. Bath, A. Adami, D. Bereczki, E. Berge, M.Z. Beridze, Lesley Cala, A. Casado, V. Caso, H. Chang, H.K. Christensen, R.D. Collins, A. Członkowska, R.A. Dineen, A.E. Etribi, A. Ghani, J.H. Gommans, P. Koumellis, A.C. Laska, K.R. Lees, J.C. NavarroG.C. Ntaios, S. Öztürk, S.J. Phillips, S.J. Pocock, K.T. Prasad, P. Scutt, H.A.R. De Silva, S.Z. Szatmári, S. Utton, Y. Wang, M.W. Joanna, D.K. Whynes, L. Wong, L.J. Woodhouse, N. Sprigg

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Background: High blood pressure is common in acute stroke and associated with a worse functional outcome. Many patients who present with acute stroke are taking prescribed antihypertensive therapy before their stroke. Aims: ENOS tested whether lowering blood pressure and continuing pre-stroke antihypertensive therapy are each safe and effective. Methods: This study is an international multi-centre prospective randomized single-blind blinded-endpoint parallel-group partial-factorial controlled trial of transdermal glyceryl trinitrate (a nitric oxide donor, given for seven-days) vs. no glyceryl trinitrate, and of continuing vs. stopping (temporarily for seven-days) pre-stroke antihypertensive drugs if relevant, in patients with acute ischaemic stroke or intracerebral haemorrhage and high systolic blood pressure (140-220mmHg). Results: Recruitment ran from July 2001 to October 2013. Four thousand eleven patients [2097 (52·3%) in the continue/stop arm] were recruited from 173 sites across 23 countries in 5 continents (Asia 14%, Continental Europe 16%, UK 64%). Baseline characteristics include: mean age 70 (standard deviation 12) years; male 57%; mean time from stroke to recruitment 26 (13) h; mean severity (Scandinavian Stroke Scale) 34 (13) of 58; mean blood pressure 167 (19)/90 (13)mmHg; ischaemic stroke 83%; and intracerebral haemorrhage 16%. The main trial results will be presented in May 2014. The results will also be presented in updated Cochrane systematic reviews and included in individual patient data meta-analyses of all relevant randomized controlled trials. Conclusion: ENOS is a large completed international trial of blood pressure management in acute stroke and includes patients representative of many stroke services worldwide. International Journal of Stroke © 2014 World Stroke Organization.

Original language	English
Pages (from-to)	711-720
Journal	International Journal of Stroke
Volume	9
Issue number	6
DOIs	https://doi.org/10.1111/ijs.12308
Publication status	Published - 2014

Access to Document

10.1111/ijs.12308

Cite this

Bath, P. M. W., Adami, A., Bereczki, D., Berge, E., Beridze, M. Z., Cala, L., Casado, A., Caso, V., Chang, H., Christensen, H. K., Collins, R. D., Członkowska, A., Dineen, R. A., Etribi, A. E., Ghani, A., Gommans, J. H., Koumellis, P., Laska, A. C., Lees, K. R., ... Sprigg, N. (2014). Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke, 9(6), 711-720. https://doi.org/10.1111/ijs.12308

@article{30fcc6a4a4654c259682777453d4c1a0,

title = "Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial",

abstract = "Background: High blood pressure is common in acute stroke and associated with a worse functional outcome. Many patients who present with acute stroke are taking prescribed antihypertensive therapy before their stroke. Aims: ENOS tested whether lowering blood pressure and continuing pre-stroke antihypertensive therapy are each safe and effective. Methods: This study is an international multi-centre prospective randomized single-blind blinded-endpoint parallel-group partial-factorial controlled trial of transdermal glyceryl trinitrate (a nitric oxide donor, given for seven-days) vs. no glyceryl trinitrate, and of continuing vs. stopping (temporarily for seven-days) pre-stroke antihypertensive drugs if relevant, in patients with acute ischaemic stroke or intracerebral haemorrhage and high systolic blood pressure (140-220mmHg). Results: Recruitment ran from July 2001 to October 2013. Four thousand eleven patients [2097 (52·3%) in the continue/stop arm] were recruited from 173 sites across 23 countries in 5 continents (Asia 14%, Continental Europe 16%, UK 64%). Baseline characteristics include: mean age 70 (standard deviation 12) years; male 57%; mean time from stroke to recruitment 26 (13) h; mean severity (Scandinavian Stroke Scale) 34 (13) of 58; mean blood pressure 167 (19)/90 (13)mmHg; ischaemic stroke 83%; and intracerebral haemorrhage 16%. The main trial results will be presented in May 2014. The results will also be presented in updated Cochrane systematic reviews and included in individual patient data meta-analyses of all relevant randomized controlled trials. Conclusion: ENOS is a large completed international trial of blood pressure management in acute stroke and includes patients representative of many stroke services worldwide. International Journal of Stroke {\textcopyright} 2014 World Stroke Organization.",

author = "P.M.W. Bath and A. Adami and D. Bereczki and E. Berge and M.Z. Beridze and Lesley Cala and A. Casado and V. Caso and H. Chang and H.K. Christensen and R.D. Collins and A. Cz{\l}onkowska and R.A. Dineen and A.E. Etribi and A. Ghani and J.H. Gommans and P. Koumellis and A.C. Laska and K.R. Lees and J.C. Navarro and G.C. Ntaios and S. {\"O}zt{\"u}rk and S.J. Phillips and S.J. Pocock and K.T. Prasad and P. Scutt and {De Silva}, H.A.R. and S.Z. Szatm{\'a}ri and S. Utton and Y. Wang and M.W. Joanna and D.K. Whynes and L. Wong and L.J. Woodhouse and N. Sprigg",

year = "2014",

doi = "10.1111/ijs.12308",

language = "English",

volume = "9",

pages = "711--720",

journal = "International Journal of Stroke",

issn = "1747-4930",

publisher = "Wiley-Blackwell",

number = "6",

}

Bath, PMW, Adami, A, Bereczki, D, Berge, E, Beridze, MZ, Cala, L, Casado, A, Caso, V, Chang, H, Christensen, HK, Collins, RD, Członkowska, A, Dineen, RA, Etribi, AE, Ghani, A, Gommans, JH, Koumellis, P, Laska, AC, Lees, KR, Navarro, JC, Ntaios, GC, Öztürk, S, Phillips, SJ, Pocock, SJ, Prasad, KT, Scutt, P, De Silva, HAR, Szatmári, SZ, Utton, S, Wang, Y, Joanna, MW, Whynes, DK, Wong, L, Woodhouse, LJ & Sprigg, N 2014, 'Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial', International Journal of Stroke, vol. 9, no. 6, pp. 711-720. https://doi.org/10.1111/ijs.12308

TY - JOUR

T1 - Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

AU - Bath, P.M.W.

AU - Adami, A.

AU - Bereczki, D.

AU - Berge, E.

AU - Beridze, M.Z.

AU - Cala, Lesley

AU - Casado, A.

AU - Caso, V.

AU - Chang, H.

AU - Christensen, H.K.

AU - Collins, R.D.

AU - Członkowska, A.

AU - Dineen, R.A.

AU - Etribi, A.E.

AU - Ghani, A.

AU - Gommans, J.H.

AU - Koumellis, P.

AU - Laska, A.C.

AU - Lees, K.R.

AU - Navarro, J.C.

AU - Ntaios, G.C.

AU - Öztürk, S.

AU - Phillips, S.J.

AU - Pocock, S.J.

AU - Prasad, K.T.

AU - Scutt, P.

AU - De Silva, H.A.R.

AU - Szatmári, S.Z.

AU - Utton, S.

AU - Wang, Y.

AU - Joanna, M.W.

AU - Whynes, D.K.

AU - Wong, L.

AU - Woodhouse, L.J.

AU - Sprigg, N.

PY - 2014

Y1 - 2014

N2 - Background: High blood pressure is common in acute stroke and associated with a worse functional outcome. Many patients who present with acute stroke are taking prescribed antihypertensive therapy before their stroke. Aims: ENOS tested whether lowering blood pressure and continuing pre-stroke antihypertensive therapy are each safe and effective. Methods: This study is an international multi-centre prospective randomized single-blind blinded-endpoint parallel-group partial-factorial controlled trial of transdermal glyceryl trinitrate (a nitric oxide donor, given for seven-days) vs. no glyceryl trinitrate, and of continuing vs. stopping (temporarily for seven-days) pre-stroke antihypertensive drugs if relevant, in patients with acute ischaemic stroke or intracerebral haemorrhage and high systolic blood pressure (140-220mmHg). Results: Recruitment ran from July 2001 to October 2013. Four thousand eleven patients [2097 (52·3%) in the continue/stop arm] were recruited from 173 sites across 23 countries in 5 continents (Asia 14%, Continental Europe 16%, UK 64%). Baseline characteristics include: mean age 70 (standard deviation 12) years; male 57%; mean time from stroke to recruitment 26 (13) h; mean severity (Scandinavian Stroke Scale) 34 (13) of 58; mean blood pressure 167 (19)/90 (13)mmHg; ischaemic stroke 83%; and intracerebral haemorrhage 16%. The main trial results will be presented in May 2014. The results will also be presented in updated Cochrane systematic reviews and included in individual patient data meta-analyses of all relevant randomized controlled trials. Conclusion: ENOS is a large completed international trial of blood pressure management in acute stroke and includes patients representative of many stroke services worldwide. International Journal of Stroke © 2014 World Stroke Organization.

AB - Background: High blood pressure is common in acute stroke and associated with a worse functional outcome. Many patients who present with acute stroke are taking prescribed antihypertensive therapy before their stroke. Aims: ENOS tested whether lowering blood pressure and continuing pre-stroke antihypertensive therapy are each safe and effective. Methods: This study is an international multi-centre prospective randomized single-blind blinded-endpoint parallel-group partial-factorial controlled trial of transdermal glyceryl trinitrate (a nitric oxide donor, given for seven-days) vs. no glyceryl trinitrate, and of continuing vs. stopping (temporarily for seven-days) pre-stroke antihypertensive drugs if relevant, in patients with acute ischaemic stroke or intracerebral haemorrhage and high systolic blood pressure (140-220mmHg). Results: Recruitment ran from July 2001 to October 2013. Four thousand eleven patients [2097 (52·3%) in the continue/stop arm] were recruited from 173 sites across 23 countries in 5 continents (Asia 14%, Continental Europe 16%, UK 64%). Baseline characteristics include: mean age 70 (standard deviation 12) years; male 57%; mean time from stroke to recruitment 26 (13) h; mean severity (Scandinavian Stroke Scale) 34 (13) of 58; mean blood pressure 167 (19)/90 (13)mmHg; ischaemic stroke 83%; and intracerebral haemorrhage 16%. The main trial results will be presented in May 2014. The results will also be presented in updated Cochrane systematic reviews and included in individual patient data meta-analyses of all relevant randomized controlled trials. Conclusion: ENOS is a large completed international trial of blood pressure management in acute stroke and includes patients representative of many stroke services worldwide. International Journal of Stroke © 2014 World Stroke Organization.

U2 - 10.1111/ijs.12308

DO - 10.1111/ijs.12308

M3 - Article

C2 - 25043647

SN - 1747-4930

VL - 9

SP - 711

EP - 720

JO - International Journal of Stroke

JF - International Journal of Stroke

IS - 6

ER -

Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial

Abstract

Access to Document

Fingerprint

Cite this